Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: Effect of ascorbic acid

Free Radical Biology and Medicine

Volumn 43, Issue 5, 2007, Pages 853-859

  Cangemi, Roberto ^a   Angelico, Francesco ^a   Loffredo, Lorenzo ^a   Del Ben, Maria ^a   Pignatelli, Pasquale ^a   Martini, Alessandra ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ascorbic acid; Flow mediated dilation; Free radicals; Metabolic syndrome; Oxidative stress

Indexed keywords

8 HYDROXY 2 DEOXY 2 DEOXYGUANOSINE; ASCORBIC ACID; DEOXYGUANOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERY DILATATION; ARTERY DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INHIBITION; HUMAN; ISCHEMIA; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ARTERIES; ASCORBIC ACID; CROSS-SECTIONAL STUDIES; DEOXYGUANINE NUCLEOTIDES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS;

EID: 34547108613     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.06.002     Document Type: Article

References (45)

1. Landmesser U., and Drexler H. The clinical significance of endothelial dysfunction. Curr. Opin. Cardiol. 20 (2005) 547-551
2. Inoue T., and Node K. Vascular failure: a new clinical entity for vascular disease. J. Hypertens. 24 (2006) 2121-2130
3. Gokce N., Keaney Jr. J.F., Hunter L.M., Watkins M.T., Menzoian J.O., and Vita J.A. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105 (2002) 1567-1572
4. Gokce N., Keaney Jr. J.F., Hunter L.M., Watkins M.T., Nedeljkovic Z.S., Menzoian J.O., and Vita J.A. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J. Am. Coll. Cardiol. 41 (2003) 1769-1775
5. Brevetti G., Silvestro A., Schiano V., and Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108 (2003) 2093-2098
6. Meyer A.A., Kundt G., Lenschow U., Schuff-Werner P., and Kienast W. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J. Am. Coll. Cardiol. 48 (2006) 1865-1870
7. Singh U., and Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 13 (2006) 129-142
8. -/- mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1753-1759
9. Ray R., and Shah A.M. NADPH oxidase and endothelial cell function. Clin. Sci. (London) 109 (2005) 217-226
10. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Oshima T., and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med. 346 (2002) 1954-1962
11. Pyke K.E., and Tschakovsky M.E. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J. Physiol. 568 (2005) 357-369
12. Panza J.A., Quyyumi A.A., Brush Jr. J.E., and Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323 (1990) 22-27
13. Jarvisalo M.J., Raitakari M., Toikka J.O., Putto-Laurila A., Rontu R., Laine S., Lehtimaki T., Ronnemaa T., Viikari J., and Raitakari O.T. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 109 (2004) 1750-1755
14. Steinberg H.O., Bayazeed B., Hook G., Johnson A., Cronin J., and Baron A.D. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 96 (1997) 3287-3293
15. Violi F., Loffredo L., Musella L., and Marcoccia A. Should antioxidant status be considered in interventional trials with antioxidants?. Heart 90 (2004) 598-602
16. Loffredo L., Marcoccia A., Pignatelli P., Andreozzi P., Borgia M.C., Cangemi R., Chiarotti F., and Violi F. Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur. Heart J. 28 (2007) 608-612
17. Violi F., Sanguigni V., Loffredo L., Carnevale R., Buchetti B., Finocchi A., Tesauro M., Rossi P., and Pignatelli P. Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: a pilot study in patients with hereditary Nox2 deficiency. Arterioscler. Thromb. Vasc. Biol. 26 (2006) e131-e132
18. Bertuglia S., and Giusti A. Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion. Am. J. Physiol.: Heart Circ. Physiol. 285 (2003) H1064-H1071
19. Gami A.S., Witt B.J., Howard D.E., Erwin P.J., Gami L.A., Somers V.K., and Montori V.M. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49 (2007) 403-414
20. May J.M. How does ascorbic acid prevent endothelial dysfunction?. Free Radic. Biol. Med. 28 (2000) 1421-1429
21. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 106 (2002) 3143-3421
22. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., Deanfield J., Drexler H., Gerhard-Herman M., Herrington D., Vallance P., Vita J., and Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39 (2002) 257-265
23. Hills M., and Armitage P. The two-period cross-over clinical trial. Br. J. Clin. Pharmacol. 8 (1979) 7-20
24. Jackson T.S., Xu A., Vita J.A., and Keaney Jr. J.F. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res. 83 (1998) 916-922
25. Hamdy O., Ledbury S., Mullooly C., Jarema C., Porter S., Ovalle K., Moussa A., Caselli A., Caballero A.E., Economides P.A., Veves A., and Horton E.S. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26 (2003) 2119-2125
26. Thomas G.N., Chook P., Qiao M., Huang X.S., Leong H.C., Celermajer D.S., and Woo K.S. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 739-743
27. Suzuki M., Takamisawa I., Suzuki K., Hiuge A., Horio T., Yoshimasa Y., and Harano Y. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. Am. J. Hypertens. 17 (2004) 228-232
28. Nestel P.J., Yamashita T., Sasahara T., Chin-Dusting J.P., Esler M.D., Dart A.M., and Jennings G.L. Control of the forearm microcirculation: interactions with measures of obesity and noradrenaline kinetics. Clin. Sci. (London) 95 (1998) 203-212
29. Brook R.D., Bard R.L., Glazewski L., Kehrer C., Bodary P.F., Eitzman D.L., and Rajagopalan S. Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am. J. Cardiol. 93 (2004) 1012-1016
30. Wendelhag I., Fagerberg B., Hulthe J., Bokemark L., and Wikstrand J. Endothelium-dependent flow-mediated vasodilatation, insulin resistance and the metabolic syndrome in 60-year-old men. J. Intern. Med. 252 (2002) 305-313
31. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., and Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
32. Crimi E., Sica V., Williams-Ignarro S., Zhang H., Slutsky A.S., Ignarro L.J., and Napoli C. The role of oxidative stress in adult critical care. Free Radic. Biol. Med. 40 (2006) 398-406
33. Duffy S.J., Gokce N., Holbrook M., Hunter L.M., Biegelsen E.S., Huang A.O., Keaney Jr. J.F., and Vita J.A. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am. J. Physiol.: Heart Circ. Physiol. 280 (2001) H528-H534
34. Erbs S., Gielen S., Linke A., Möbius-Winkler S., Adams V., Baither Y., Schuler G., and Hambrecht R. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am. Heart J. 146 (2003) 280-285
35. Heitzer T., Just H., and Münzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94 (1996) 6-9
36. Hornig B., Arakawa N., Kohler C., and Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97 (1998) 363-368
37. Ting H.H., Timimi F.K., Haley E.A., Roddy M.A., Ganz P., and Creager M.A. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 95 (1997) 2617-2622
38. Noma K., Goto C., Nishioka K., Jitsuiki D., Umemura T., Ueda K., Kimura M., Nakagawa K., Oshima T., Chayama K., Yoshizumi M., Liao J.K., and Higashi Y. Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness. J. Am. Coll. Cardiol. 49 (2007) 698-705
39. Wu L.L., Chiou C.C., Chang P.Y., and Wu J.T. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin. Chim. Acta 339 (2004) 1-9
40. Pratico D., Barry O.P., Lawson J.A., Adiyaman M., Hwang S.W., Khanapure S.P., Iuliano L., Rokach J., and FitzGerald G.A. IPF2alpha-I: an index of lipid peroxidation in humans. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3449-3454
41. Padayatty S.J., Sun H., Wang Y., Riordan H.D., Hewitt S.M., Katz A., Wesley R.A., and Levine M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann. Intern. Med. 140 (2004) 533-537
42. Bell C., Carson J.M., Motte N.W., and Seals D.R. Ascorbic acid does not affect the age-associated reduction in maximal cardiac output and oxygen consumption in healthy adults. J. Appl. Physiol. 98 (2005) 845-849
43. Padayatty S.J., Katz A., Wang Y., Eck P., Kwon O., Lee J.H., Chen S., Corpe C., Dutta A., Dutta S.K., and Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J. Am. Coll. Nutr. 22 (2003) 18-35
44. Heller R., Münscher-Paulig F., Gräbner R., and Till U. l-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J. Biol. Chem. 274 (1999) 8254-8260
45. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayer G., and Werner E.R. l-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J. Biol. Chem. 276 (2001) 40-47